nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—ORM1—Quinidine—malaria	0.0578	0.0862	CbGbCtD
Erlotinib—CYP2C8—Pyrimethamine—malaria	0.0415	0.0619	CbGbCtD
Erlotinib—CYP2C8—Sulfadiazine—malaria	0.0415	0.0619	CbGbCtD
Erlotinib—CYP1A1—Quinine—malaria	0.0371	0.0553	CbGbCtD
Erlotinib—CYP3A5—Artemether—malaria	0.0367	0.0548	CbGbCtD
Erlotinib—CYP1A1—Quinidine—malaria	0.0326	0.0486	CbGbCtD
Erlotinib—CYP3A4—Clindamycin—malaria	0.0293	0.0437	CbGbCtD
Erlotinib—CYP2D6—Pyrimethamine—malaria	0.0265	0.0395	CbGbCtD
Erlotinib—CYP1A2—Proguanil—malaria	0.0257	0.0383	CbGbCtD
Erlotinib—CYP2D6—Artemether—malaria	0.0225	0.0336	CbGbCtD
Erlotinib—CYP3A5—Quinine—malaria	0.0222	0.0332	CbGbCtD
Erlotinib—CYP2C8—Quinine—malaria	0.0214	0.0319	CbGbCtD
Erlotinib—CYP2D6—Proguanil—malaria	0.0212	0.0316	CbGbCtD
Erlotinib—CYP2D6—Quinidine barbiturate—malaria	0.0201	0.0299	CbGbCtD
Erlotinib—CYP2C8—Quinidine—malaria	0.0188	0.028	CbGbCtD
Erlotinib—CYP1A2—Pentoxifylline—malaria	0.0185	0.0275	CbGbCtD
Erlotinib—CYP3A5—Dapsone—malaria	0.0169	0.0251	CbGbCtD
Erlotinib—CYP3A4—Sulfadiazine—malaria	0.0168	0.0251	CbGbCtD
Erlotinib—CYP1A2—Quinine—malaria	0.0166	0.0247	CbGbCtD
Erlotinib—CYP2C8—Dapsone—malaria	0.0162	0.0242	CbGbCtD
Erlotinib—CYP1A2—Quinidine—malaria	0.0146	0.0217	CbGbCtD
Erlotinib—ABCB1—Quinine—malaria	0.0145	0.0216	CbGbCtD
Erlotinib—CYP3A4—Artemether—malaria	0.0143	0.0214	CbGbCtD
Erlotinib—CYP2D6—Quinine—malaria	0.0136	0.0203	CbGbCtD
Erlotinib—CYP3A4—Proguanil—malaria	0.0135	0.0201	CbGbCtD
Erlotinib—CYP3A4—Doxycycline—malaria	0.0128	0.019	CbGbCtD
Erlotinib—ABCB1—Quinidine—malaria	0.0127	0.019	CbGbCtD
Erlotinib—CYP2D6—Quinidine—malaria	0.012	0.0179	CbGbCtD
Erlotinib—CYP3A4—Quinine—malaria	0.00868	0.0129	CbGbCtD
Erlotinib—CYP3A4—Quinidine—malaria	0.00763	0.0114	CbGbCtD
Erlotinib—CYP3A4—Dapsone—malaria	0.00658	0.0098	CbGbCtD
Erlotinib—ORM1—saliva—malaria	0.00391	0.0342	CbGeAlD
Erlotinib—FLT3—blood plasma—malaria	0.00352	0.0307	CbGeAlD
Erlotinib—Vandetanib—KDR—malaria	0.00287	1	CrCbGaD
Erlotinib—JAK3—hematopoietic system—malaria	0.00246	0.0215	CbGeAlD
Erlotinib—STK10—blood plasma—malaria	0.00235	0.0205	CbGeAlD
Erlotinib—UGT1A1—blood plasma—malaria	0.00222	0.0194	CbGeAlD
Erlotinib—NR1I2—digestive system—malaria	0.00214	0.0187	CbGeAlD
Erlotinib—FLT3—hematopoietic system—malaria	0.00194	0.017	CbGeAlD
Erlotinib—PIP4K2C—saliva-secreting gland—malaria	0.00184	0.0161	CbGeAlD
Erlotinib—ULK3—saliva-secreting gland—malaria	0.00176	0.0153	CbGeAlD
Erlotinib—JAK3—digestive system—malaria	0.00171	0.015	CbGeAlD
Erlotinib—ULK3—hematopoietic system—malaria	0.00168	0.0146	CbGeAlD
Erlotinib—JAK3—blood—malaria	0.00163	0.0143	CbGeAlD
Erlotinib—NR1I2—liver—malaria	0.0016	0.014	CbGeAlD
Erlotinib—MKNK1—hematopoietic system—malaria	0.00158	0.0138	CbGeAlD
Erlotinib—SLK—saliva-secreting gland—malaria	0.00157	0.0137	CbGeAlD
Erlotinib—TNK1—blood—malaria	0.0015	0.0131	CbGeAlD
Erlotinib—STK10—hematopoietic system—malaria	0.0013	0.0114	CbGeAlD
Erlotinib—FLT3—blood—malaria	0.00129	0.0113	CbGeAlD
Erlotinib—HIPK4—brain—malaria	0.00128	0.0112	CbGeAlD
Erlotinib—LTK—brain—malaria	0.00127	0.0111	CbGeAlD
Erlotinib—FLT3—bone marrow—malaria	0.00125	0.0109	CbGeAlD
Erlotinib—ABL2—blood—malaria	0.00123	0.0107	CbGeAlD
Erlotinib—UGT1A1—hematopoietic system—malaria	0.00123	0.0107	CbGeAlD
Erlotinib—MAP2K5—saliva-secreting gland—malaria	0.00122	0.0106	CbGeAlD
Erlotinib—TNK1—liver—malaria	0.00117	0.0102	CbGeAlD
Erlotinib—ULK3—digestive system—malaria	0.00117	0.0102	CbGeAlD
Erlotinib—PIP4K2C—blood—malaria	0.00116	0.0102	CbGeAlD
Erlotinib—PIP4K2C—bone marrow—malaria	0.00113	0.00983	CbGeAlD
Erlotinib—ULK3—blood—malaria	0.00111	0.0097	CbGeAlD
Erlotinib—MKNK1—digestive system—malaria	0.0011	0.00959	CbGeAlD
Erlotinib—AURKC—brain—malaria	0.00109	0.00956	CbGeAlD
Erlotinib—ULK3—bone marrow—malaria	0.00107	0.00939	CbGeAlD
Erlotinib—STK10—kidney—malaria	0.00107	0.00931	CbGeAlD
Erlotinib—CYP2C8—blood plasma—malaria	0.00105	0.00917	CbGeAlD
Erlotinib—MKNK1—blood—malaria	0.00105	0.00913	CbGeAlD
Erlotinib—EPHA6—brain—malaria	0.00101	0.00885	CbGeAlD
Erlotinib—JAK3—brain—malaria	0.00101	0.00885	CbGeAlD
Erlotinib—MKNK1—bone marrow—malaria	0.00101	0.00884	CbGeAlD
Erlotinib—FLT3—liver—malaria	0.00101	0.0088	CbGeAlD
Erlotinib—UGT1A1—kidney—malaria	0.00101	0.00879	CbGeAlD
Erlotinib—SLK—blood—malaria	0.00099	0.00865	CbGeAlD
Erlotinib—CYP1A2—blood plasma—malaria	0.000982	0.00858	CbGeAlD
Erlotinib—ABL2—liver—malaria	0.000961	0.0084	CbGeAlD
Erlotinib—SLK—bone marrow—malaria	0.000958	0.00837	CbGeAlD
Erlotinib—CYP3A5—blood plasma—malaria	0.000948	0.00828	CbGeAlD
Erlotinib—ORM1—hematopoietic system—malaria	0.000942	0.00823	CbGeAlD
Erlotinib—EGFR—liver—malaria	0.000938	0.0082	CbGeAlD
Erlotinib—ABL1—saliva-secreting gland—malaria	0.000938	0.0082	CbGeAlD
Erlotinib—TNK1—brain—malaria	0.00093	0.00813	CbGeAlD
Erlotinib—MAP3K19—brain—malaria	0.000921	0.00804	CbGeAlD
Erlotinib—PIP4K2C—liver—malaria	0.00091	0.00795	CbGeAlD
Erlotinib—STK10—digestive system—malaria	0.000904	0.00789	CbGeAlD
Erlotinib—SLCO2B1—hematopoietic system—malaria	0.000903	0.00789	CbGeAlD
Erlotinib—ABL1—hematopoietic system—malaria	0.000895	0.00782	CbGeAlD
Erlotinib—ULK3—liver—malaria	0.000869	0.00759	CbGeAlD
Erlotinib—STK10—blood—malaria	0.000861	0.00752	CbGeAlD
Erlotinib—UGT1A1—digestive system—malaria	0.000853	0.00746	CbGeAlD
Erlotinib—STK10—bone marrow—malaria	0.000833	0.00728	CbGeAlD
Erlotinib—MKNK1—liver—malaria	0.000817	0.00714	CbGeAlD
Erlotinib—UGT1A1—blood—malaria	0.000813	0.0071	CbGeAlD
Erlotinib—Nervous system disorder—Proguanil—malaria	0.000782	0.00489	CcSEcCtD
Erlotinib—Skin disorder—Proguanil—malaria	0.000775	0.00484	CcSEcCtD
Erlotinib—SLK—liver—malaria	0.000774	0.00676	CbGeAlD
Erlotinib—Renal failure acute—Quinidine barbiturate—malaria	0.000769	0.00481	CcSEcCtD
Erlotinib—MAP2K5—blood—malaria	0.000769	0.00672	CbGeAlD
Erlotinib—ABL2—brain—malaria	0.000763	0.00667	CbGeAlD
Erlotinib—Anorexia—Proguanil—malaria	0.00076	0.00475	CcSEcCtD
Erlotinib—CYP1B1—hematopoietic system—malaria	0.000758	0.00662	CbGeAlD
Erlotinib—Renal impairment—Quinidine barbiturate—malaria	0.000746	0.00467	CcSEcCtD
Erlotinib—Hepatitis—Sulfadiazine—malaria	0.000745	0.00466	CcSEcCtD
Erlotinib—EGFR—brain—malaria	0.000745	0.00651	CbGeAlD
Erlotinib—Dermatitis bullous—Quinidine barbiturate—malaria	0.000743	0.00465	CcSEcCtD
Erlotinib—SLCO2B1—kidney—malaria	0.00074	0.00647	CbGeAlD
Erlotinib—Dry skin—Clindamycin—malaria	0.000735	0.0046	CcSEcCtD
Erlotinib—ABL1—kidney—malaria	0.000734	0.00641	CbGeAlD
Erlotinib—Toxic epidermal necrolysis—Clindamycin—malaria	0.000722	0.00452	CcSEcCtD
Erlotinib—PIP4K2C—brain—malaria	0.000722	0.00631	CbGeAlD
Erlotinib—CYP3A4—blood plasma—malaria	0.000711	0.00621	CbGeAlD
Erlotinib—Toxic epidermal necrolysis—Quinidine—malaria	0.000708	0.00443	CcSEcCtD
Erlotinib—Toxic epidermal necrolysis—Quinine—malaria	0.000708	0.00443	CcSEcCtD
Erlotinib—Erythema multiforme—Sulfadiazine—malaria	0.000704	0.00441	CcSEcCtD
Erlotinib—Pancreatitis—Dapsone—malaria	0.000703	0.00439	CcSEcCtD
Erlotinib—CYP2D6—blood plasma—malaria	0.0007	0.00611	CbGeAlD
Erlotinib—Decreased appetite—Proguanil—malaria	0.000693	0.00434	CcSEcCtD
Erlotinib—ULK3—brain—malaria	0.000689	0.00602	CbGeAlD
Erlotinib—Gastrointestinal disorder—Proguanil—malaria	0.000688	0.00431	CcSEcCtD
Erlotinib—STK10—liver—malaria	0.000673	0.00588	CbGeAlD
Erlotinib—Chills—Sulfadiazine—malaria	0.000668	0.00418	CcSEcCtD
Erlotinib—Gastrointestinal pain—Proguanil—malaria	0.000652	0.00408	CcSEcCtD
Erlotinib—Vomiting—Pyrimethamine—malaria	0.000651	0.00407	CcSEcCtD
Erlotinib—MKNK1—brain—malaria	0.000649	0.00567	CbGeAlD
Erlotinib—Neutropenia—Clindamycin—malaria	0.000648	0.00405	CcSEcCtD
Erlotinib—Toxic epidermal necrolysis—Quinidine barbiturate—malaria	0.000639	0.004	CcSEcCtD
Erlotinib—Neutropenia—Quinine—malaria	0.000636	0.00398	CcSEcCtD
Erlotinib—Neutropenia—Quinidine—malaria	0.000636	0.00398	CcSEcCtD
Erlotinib—UGT1A1—liver—malaria	0.000636	0.00555	CbGeAlD
Erlotinib—Body temperature increased—Proguanil—malaria	0.00063	0.00394	CcSEcCtD
Erlotinib—Abdominal pain—Proguanil—malaria	0.00063	0.00394	CcSEcCtD
Erlotinib—SLCO2B1—digestive system—malaria	0.000628	0.00549	CbGeAlD
Erlotinib—Neuropathy peripheral—Dapsone—malaria	0.000626	0.00392	CcSEcCtD
Erlotinib—ORM1—blood—malaria	0.000624	0.00545	CbGeAlD
Erlotinib—ABL1—digestive system—malaria	0.000622	0.00544	CbGeAlD
Erlotinib—CYP1B1—kidney—malaria	0.000621	0.00543	CbGeAlD
Erlotinib—SLK—brain—malaria	0.000614	0.00537	CbGeAlD
Erlotinib—Stevens-Johnson syndrome—Clindamycin—malaria	0.000613	0.00383	CcSEcCtD
Erlotinib—ORM1—bone marrow—malaria	0.000604	0.00528	CbGeAlD
Erlotinib—MAP2K5—liver—malaria	0.000601	0.00525	CbGeAlD
Erlotinib—Stevens-Johnson syndrome—Quinidine—malaria	0.000601	0.00376	CcSEcCtD
Erlotinib—Stevens-Johnson syndrome—Quinine—malaria	0.000601	0.00376	CcSEcCtD
Erlotinib—Renal failure—Quinidine—malaria	0.000596	0.00373	CcSEcCtD
Erlotinib—Renal failure—Quinine—malaria	0.000596	0.00373	CcSEcCtD
Erlotinib—ABL1—blood—malaria	0.000593	0.00518	CbGeAlD
Erlotinib—ABCG2—saliva-secreting gland—malaria	0.000591	0.00517	CbGeAlD
Erlotinib—Epistaxis—Clindamycin—malaria	0.000583	0.00365	CcSEcCtD
Erlotinib—CYP2C8—hematopoietic system—malaria	0.000581	0.00507	CbGeAlD
Erlotinib—ABL1—bone marrow—malaria	0.000574	0.00501	CbGeAlD
Erlotinib—Neutropenia—Quinidine barbiturate—malaria	0.000574	0.00359	CcSEcCtD
Erlotinib—Arthralgia—Sulfadiazine—malaria	0.000552	0.00345	CcSEcCtD
Erlotinib—Haemoglobin—Quinidine—malaria	0.000547	0.00342	CcSEcCtD
Erlotinib—Haemoglobin—Quinine—malaria	0.000547	0.00342	CcSEcCtD
Erlotinib—Infestation—Pentoxifylline—malaria	0.000546	0.00342	CcSEcCtD
Erlotinib—Infestation NOS—Pentoxifylline—malaria	0.000546	0.00342	CcSEcCtD
Erlotinib—Diarrhoea—Proguanil—malaria	0.000546	0.00341	CcSEcCtD
Erlotinib—Hepatitis—Quinine—malaria	0.000544	0.0034	CcSEcCtD
Erlotinib—Haemorrhage—Quinidine—malaria	0.000544	0.0034	CcSEcCtD
Erlotinib—Haemorrhage—Quinine—malaria	0.000544	0.0034	CcSEcCtD
Erlotinib—Hepatitis—Quinidine—malaria	0.000544	0.0034	CcSEcCtD
Erlotinib—CYP1A2—hematopoietic system—malaria	0.000543	0.00475	CbGeAlD
Erlotinib—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.000542	0.00339	CcSEcCtD
Erlotinib—Renal failure—Quinidine barbiturate—malaria	0.000538	0.00336	CcSEcCtD
Erlotinib—Urinary tract disorder—Quinine—malaria	0.000537	0.00336	CcSEcCtD
Erlotinib—Urinary tract disorder—Quinidine—malaria	0.000537	0.00336	CcSEcCtD
Erlotinib—CYP1A1—hematopoietic system—malaria	0.000536	0.00468	CbGeAlD
Erlotinib—STK10—brain—malaria	0.000534	0.00467	CbGeAlD
Erlotinib—Urethral disorder—Quinine—malaria	0.000533	0.00334	CcSEcCtD
Erlotinib—Urethral disorder—Quinidine—malaria	0.000533	0.00334	CcSEcCtD
Erlotinib—Conjunctivitis—Pentoxifylline—malaria	0.000531	0.00332	CcSEcCtD
Erlotinib—CYP1B1—digestive system—malaria	0.000527	0.00461	CbGeAlD
Erlotinib—Erythema multiforme—Clindamycin—malaria	0.000525	0.00328	CcSEcCtD
Erlotinib—CYP3A5—hematopoietic system—malaria	0.000524	0.00458	CbGeAlD
Erlotinib—Thrombocytopenia—Sulfadiazine—malaria	0.000518	0.00324	CcSEcCtD
Erlotinib—Hepatobiliary disease—Pentoxifylline—malaria	0.000517	0.00323	CcSEcCtD
Erlotinib—Epistaxis—Pentoxifylline—malaria	0.000515	0.00322	CcSEcCtD
Erlotinib—Erythema multiforme—Quinidine—malaria	0.000515	0.00322	CcSEcCtD
Erlotinib—Erythema multiforme—Quinine—malaria	0.000515	0.00322	CcSEcCtD
Erlotinib—Eye disorder—Quinine—malaria	0.000509	0.00318	CcSEcCtD
Erlotinib—Eye disorder—Quinidine—malaria	0.000509	0.00318	CcSEcCtD
Erlotinib—Vomiting—Proguanil—malaria	0.000507	0.00317	CcSEcCtD
Erlotinib—Anorexia—Sulfadiazine—malaria	0.000505	0.00316	CcSEcCtD
Erlotinib—ABCB1—blood plasma—malaria	0.000503	0.0044	CbGeAlD
Erlotinib—Rash—Proguanil—malaria	0.000503	0.00314	CcSEcCtD
Erlotinib—Dermatitis—Proguanil—malaria	0.000502	0.00314	CcSEcCtD
Erlotinib—CYP1B1—blood—malaria	0.000502	0.00439	CbGeAlD
Erlotinib—Headache—Proguanil—malaria	0.0005	0.00312	CcSEcCtD
Erlotinib—Erythema—Dapsone—malaria	0.000499	0.00312	CcSEcCtD
Erlotinib—Haemoglobin—Quinidine barbiturate—malaria	0.000494	0.00309	CcSEcCtD
Erlotinib—Haemoglobin—Pentoxifylline—malaria	0.000493	0.00308	CcSEcCtD
Erlotinib—Hepatitis—Quinidine barbiturate—malaria	0.000491	0.00307	CcSEcCtD
Erlotinib—Haemorrhage—Quinidine barbiturate—malaria	0.000491	0.00307	CcSEcCtD
Erlotinib—Mediastinal disorder—Quinidine—malaria	0.00049	0.00307	CcSEcCtD
Erlotinib—Mediastinal disorder—Quinine—malaria	0.00049	0.00307	CcSEcCtD
Erlotinib—Haemorrhage—Pentoxifylline—malaria	0.00049	0.00307	CcSEcCtD
Erlotinib—Hepatitis—Pentoxifylline—malaria	0.00049	0.00307	CcSEcCtD
Erlotinib—Chills—Quinine—malaria	0.000488	0.00305	CcSEcCtD
Erlotinib—Chills—Quinidine—malaria	0.000488	0.00305	CcSEcCtD
Erlotinib—ORM1—liver—malaria	0.000488	0.00426	CbGeAlD
Erlotinib—Urinary tract disorder—Quinidine barbiturate—malaria	0.000485	0.00303	CcSEcCtD
Erlotinib—Erythema—Clindamycin—malaria	0.000483	0.00302	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000482	0.00302	CcSEcCtD
Erlotinib—Urethral disorder—Quinidine barbiturate—malaria	0.000481	0.00301	CcSEcCtD
Erlotinib—Insomnia—Sulfadiazine—malaria	0.000479	0.00299	CcSEcCtD
Erlotinib—MAP2K5—brain—malaria	0.000477	0.00417	CbGeAlD
Erlotinib—Mental disorder—Quinidine—malaria	0.000477	0.00298	CcSEcCtD
Erlotinib—Mental disorder—Quinine—malaria	0.000477	0.00298	CcSEcCtD
Erlotinib—Flatulence—Clindamycin—malaria	0.000476	0.00298	CcSEcCtD
Erlotinib—CYP2C8—kidney—malaria	0.000476	0.00416	CbGeAlD
Erlotinib—Erythema—Quinine—malaria	0.000474	0.00296	CcSEcCtD
Erlotinib—Erythema—Quinidine—malaria	0.000474	0.00296	CcSEcCtD
Erlotinib—Malnutrition—Quinidine—malaria	0.000474	0.00296	CcSEcCtD
Erlotinib—Malnutrition—Quinine—malaria	0.000474	0.00296	CcSEcCtD
Erlotinib—Nausea—Proguanil—malaria	0.000474	0.00296	CcSEcCtD
Erlotinib—SLCO2B1—liver—malaria	0.000468	0.00409	CbGeAlD
Erlotinib—Back pain—Clindamycin—malaria	0.000467	0.00292	CcSEcCtD
Erlotinib—Erythema multiforme—Quinidine barbiturate—malaria	0.000464	0.0029	CcSEcCtD
Erlotinib—ABL1—liver—malaria	0.000464	0.00405	CbGeAlD
Erlotinib—Decreased appetite—Sulfadiazine—malaria	0.00046	0.00288	CcSEcCtD
Erlotinib—Eye disorder—Quinidine barbiturate—malaria	0.000459	0.00287	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000457	0.00286	CcSEcCtD
Erlotinib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000443	0.00277	CcSEcCtD
Erlotinib—Chills—Quinidine barbiturate—malaria	0.000441	0.00276	CcSEcCtD
Erlotinib—CYP1A1—kidney—malaria	0.000439	0.00384	CbGeAlD
Erlotinib—Arrhythmia—Pentoxifylline—malaria	0.000438	0.00274	CcSEcCtD
Erlotinib—Cough—Dapsone—malaria	0.000436	0.00273	CcSEcCtD
Erlotinib—Gastrointestinal pain—Sulfadiazine—malaria	0.000433	0.00271	CcSEcCtD
Erlotinib—Mental disorder—Quinidine barbiturate—malaria	0.00043	0.00269	CcSEcCtD
Erlotinib—CYP3A5—kidney—malaria	0.000429	0.00375	CbGeAlD
Erlotinib—ALB—liver—malaria	0.000428	0.00374	CbGeAlD
Erlotinib—Malnutrition—Quinidine barbiturate—malaria	0.000428	0.00267	CcSEcCtD
Erlotinib—Erythema—Quinidine barbiturate—malaria	0.000428	0.00267	CcSEcCtD
Erlotinib—Erythema—Pentoxifylline—malaria	0.000427	0.00267	CcSEcCtD
Erlotinib—Syncope—Quinine—malaria	0.000425	0.00266	CcSEcCtD
Erlotinib—Syncope—Quinidine—malaria	0.000425	0.00266	CcSEcCtD
Erlotinib—Flatulence—Pentoxifylline—malaria	0.000421	0.00263	CcSEcCtD
Erlotinib—Body temperature increased—Sulfadiazine—malaria	0.000418	0.00262	CcSEcCtD
Erlotinib—Abdominal pain—Sulfadiazine—malaria	0.000418	0.00262	CcSEcCtD
Erlotinib—Loss of consciousness—Quinidine—malaria	0.000416	0.0026	CcSEcCtD
Erlotinib—Loss of consciousness—Quinine—malaria	0.000416	0.0026	CcSEcCtD
Erlotinib—Back pain—Pentoxifylline—malaria	0.000413	0.00258	CcSEcCtD
Erlotinib—Myalgia—Quinidine—malaria	0.000403	0.00252	CcSEcCtD
Erlotinib—Chest pain—Quinine—malaria	0.000403	0.00252	CcSEcCtD
Erlotinib—Myalgia—Quinine—malaria	0.000403	0.00252	CcSEcCtD
Erlotinib—Chest pain—Quinidine—malaria	0.000403	0.00252	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000401	0.00251	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000401	0.00251	CcSEcCtD
Erlotinib—CYP3A4—hematopoietic system—malaria	0.000393	0.00344	CbGeAlD
Erlotinib—CYP1B1—liver—malaria	0.000393	0.00343	CbGeAlD
Erlotinib—CYP2D6—hematopoietic system—malaria	0.000387	0.00338	CbGeAlD
Erlotinib—Oedema—Quinine—malaria	0.000387	0.00242	CcSEcCtD
Erlotinib—Oedema—Quinidine—malaria	0.000387	0.00242	CcSEcCtD
Erlotinib—Thrombocytopenia—Clindamycin—malaria	0.000386	0.00241	CcSEcCtD
Erlotinib—CYP2C8—blood—malaria	0.000385	0.00336	CbGeAlD
Erlotinib—Syncope—Quinidine barbiturate—malaria	0.000383	0.0024	CcSEcCtD
Erlotinib—Shock—Quinidine—malaria	0.00038	0.00238	CcSEcCtD
Erlotinib—Shock—Quinine—malaria	0.00038	0.00238	CcSEcCtD
Erlotinib—Nervous system disorder—Quinidine—malaria	0.000379	0.00237	CcSEcCtD
Erlotinib—Nervous system disorder—Quinine—malaria	0.000379	0.00237	CcSEcCtD
Erlotinib—Thrombocytopenia—Quinidine—malaria	0.000379	0.00237	CcSEcCtD
Erlotinib—Thrombocytopenia—Quinine—malaria	0.000379	0.00237	CcSEcCtD
Erlotinib—CYP1A2—digestive system—malaria	0.000378	0.0033	CbGeAlD
Erlotinib—Loss of consciousness—Quinidine barbiturate—malaria	0.000376	0.00235	CcSEcCtD
Erlotinib—Skin disorder—Quinidine—malaria	0.000376	0.00235	CcSEcCtD
Erlotinib—Skin disorder—Quinine—malaria	0.000376	0.00235	CcSEcCtD
Erlotinib—Pruritus—Sulfadiazine—malaria	0.000374	0.00234	CcSEcCtD
Erlotinib—ABCG2—blood—malaria	0.000374	0.00327	CbGeAlD
Erlotinib—CYP1A1—digestive system—malaria	0.000373	0.00326	CbGeAlD
Erlotinib—SLCO2B1—brain—malaria	0.000371	0.00324	CbGeAlD
Erlotinib—Anorexia—Quinine—malaria	0.000369	0.00231	CcSEcCtD
Erlotinib—Anorexia—Quinidine—malaria	0.000369	0.00231	CcSEcCtD
Erlotinib—Insomnia—Dapsone—malaria	0.000369	0.00231	CcSEcCtD
Erlotinib—ABL1—brain—malaria	0.000368	0.00322	CbGeAlD
Erlotinib—CYP3A5—digestive system—malaria	0.000364	0.00318	CbGeAlD
Erlotinib—Arthralgia—Quinidine barbiturate—malaria	0.000364	0.00228	CcSEcCtD
Erlotinib—Chest pain—Quinidine barbiturate—malaria	0.000364	0.00228	CcSEcCtD
Erlotinib—Myalgia—Quinidine barbiturate—malaria	0.000364	0.00228	CcSEcCtD
Erlotinib—Chest pain—Pentoxifylline—malaria	0.000363	0.00227	CcSEcCtD
Erlotinib—Myalgia—Pentoxifylline—malaria	0.000363	0.00227	CcSEcCtD
Erlotinib—Anxiety—Quinidine barbiturate—malaria	0.000363	0.00227	CcSEcCtD
Erlotinib—Diarrhoea—Sulfadiazine—malaria	0.000362	0.00227	CcSEcCtD
Erlotinib—Anxiety—Pentoxifylline—malaria	0.000362	0.00226	CcSEcCtD
Erlotinib—ABCG2—bone marrow—malaria	0.000362	0.00316	CbGeAlD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000362	0.00226	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000361	0.00226	CcSEcCtD
Erlotinib—CYP1A2—blood—malaria	0.00036	0.00314	CbGeAlD
Erlotinib—CYP1A1—blood—malaria	0.000355	0.0031	CbGeAlD
Erlotinib—Musculoskeletal discomfort—Quinidine—malaria	0.000352	0.0022	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Quinine—malaria	0.000352	0.0022	CcSEcCtD
Erlotinib—Dyspnoea—Clindamycin—malaria	0.000351	0.0022	CcSEcCtD
Erlotinib—Oedema—Quinidine barbiturate—malaria	0.000349	0.00218	CcSEcCtD
Erlotinib—Oedema—Pentoxifylline—malaria	0.000348	0.00218	CcSEcCtD
Erlotinib—CYP3A5—blood—malaria	0.000347	0.00303	CbGeAlD
Erlotinib—Dyspepsia—Clindamycin—malaria	0.000347	0.00217	CcSEcCtD
Erlotinib—Infection—Pentoxifylline—malaria	0.000346	0.00216	CcSEcCtD
Erlotinib—Dyspnoea—Quinidine—malaria	0.000345	0.00216	CcSEcCtD
Erlotinib—Dyspnoea—Quinine—malaria	0.000345	0.00216	CcSEcCtD
Erlotinib—Shock—Quinidine barbiturate—malaria	0.000343	0.00215	CcSEcCtD
Erlotinib—Shock—Pentoxifylline—malaria	0.000343	0.00214	CcSEcCtD
Erlotinib—Nervous system disorder—Quinidine barbiturate—malaria	0.000342	0.00214	CcSEcCtD
Erlotinib—Thrombocytopenia—Quinidine barbiturate—malaria	0.000342	0.00214	CcSEcCtD
Erlotinib—Thrombocytopenia—Pentoxifylline—malaria	0.000341	0.00213	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Clindamycin—malaria	0.00034	0.00213	CcSEcCtD
Erlotinib—Fatigue—Clindamycin—malaria	0.00034	0.00213	CcSEcCtD
Erlotinib—ALB—brain—malaria	0.00034	0.00297	CbGeAlD
Erlotinib—Skin disorder—Quinidine barbiturate—malaria	0.000339	0.00212	CcSEcCtD
Erlotinib—Skin disorder—Pentoxifylline—malaria	0.000338	0.00212	CcSEcCtD
Erlotinib—Pain—Clindamycin—malaria	0.000337	0.00211	CcSEcCtD
Erlotinib—Constipation—Clindamycin—malaria	0.000337	0.00211	CcSEcCtD
Erlotinib—Vomiting—Sulfadiazine—malaria	0.000337	0.0021	CcSEcCtD
Erlotinib—Decreased appetite—Quinine—malaria	0.000336	0.0021	CcSEcCtD
Erlotinib—Decreased appetite—Quinidine—malaria	0.000336	0.0021	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Quinine—malaria	0.000334	0.00209	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Quinidine—malaria	0.000334	0.00209	CcSEcCtD
Erlotinib—Rash—Sulfadiazine—malaria	0.000334	0.00209	CcSEcCtD
Erlotinib—Dermatitis—Sulfadiazine—malaria	0.000333	0.00209	CcSEcCtD
Erlotinib—Gastrointestinal pain—Dapsone—malaria	0.000333	0.00208	CcSEcCtD
Erlotinib—Anorexia—Quinidine barbiturate—malaria	0.000333	0.00208	CcSEcCtD
Erlotinib—Anorexia—Pentoxifylline—malaria	0.000332	0.00208	CcSEcCtD
Erlotinib—Headache—Sulfadiazine—malaria	0.000332	0.00207	CcSEcCtD
Erlotinib—CYP3A4—kidney—malaria	0.000322	0.00282	CbGeAlD
Erlotinib—Gastrointestinal pain—Clindamycin—malaria	0.000322	0.00202	CcSEcCtD
Erlotinib—Body temperature increased—Dapsone—malaria	0.000322	0.00201	CcSEcCtD
Erlotinib—Abdominal pain—Dapsone—malaria	0.000322	0.00201	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000318	0.00199	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000317	0.00198	CcSEcCtD
Erlotinib—CYP2D6—kidney—malaria	0.000317	0.00277	CbGeAlD
Erlotinib—Gastrointestinal pain—Quinidine—malaria	0.000316	0.00198	CcSEcCtD
Erlotinib—Gastrointestinal pain—Quinine—malaria	0.000316	0.00198	CcSEcCtD
Erlotinib—Insomnia—Pentoxifylline—malaria	0.000315	0.00197	CcSEcCtD
Erlotinib—Nausea—Sulfadiazine—malaria	0.000314	0.00197	CcSEcCtD
Erlotinib—CYP1B1—brain—malaria	0.000312	0.00272	CbGeAlD
Erlotinib—Abdominal pain—Clindamycin—malaria	0.000312	0.00195	CcSEcCtD
Erlotinib—Body temperature increased—Clindamycin—malaria	0.000312	0.00195	CcSEcCtD
Erlotinib—Dyspnoea—Quinidine barbiturate—malaria	0.000311	0.00195	CcSEcCtD
Erlotinib—Dyspnoea—Pentoxifylline—malaria	0.000311	0.00194	CcSEcCtD
Erlotinib—Dyspepsia—Pentoxifylline—malaria	0.000307	0.00192	CcSEcCtD
Erlotinib—Abdominal pain—Quinine—malaria	0.000306	0.00191	CcSEcCtD
Erlotinib—Body temperature increased—Quinidine—malaria	0.000306	0.00191	CcSEcCtD
Erlotinib—Body temperature increased—Quinine—malaria	0.000306	0.00191	CcSEcCtD
Erlotinib—Abdominal pain—Quinidine—malaria	0.000306	0.00191	CcSEcCtD
Erlotinib—Decreased appetite—Quinidine barbiturate—malaria	0.000303	0.0019	CcSEcCtD
Erlotinib—Decreased appetite—Pentoxifylline—malaria	0.000303	0.00189	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000301	0.00188	CcSEcCtD
Erlotinib—CYP2C8—liver—malaria	0.000301	0.00263	CbGeAlD
Erlotinib—Constipation—Quinidine barbiturate—malaria	0.000298	0.00187	CcSEcCtD
Erlotinib—Pain—Quinidine barbiturate—malaria	0.000298	0.00187	CcSEcCtD
Erlotinib—Constipation—Pentoxifylline—malaria	0.000298	0.00186	CcSEcCtD
Erlotinib—ABCG2—liver—malaria	0.000292	0.00256	CbGeAlD
Erlotinib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000285	0.00178	CcSEcCtD
Erlotinib—Gastrointestinal pain—Pentoxifylline—malaria	0.000285	0.00178	CcSEcCtD
Erlotinib—Asthenia—Clindamycin—malaria	0.000283	0.00177	CcSEcCtD
Erlotinib—CYP1A2—liver—malaria	0.000281	0.00246	CbGeAlD
Erlotinib—Pruritus—Clindamycin—malaria	0.000279	0.00174	CcSEcCtD
Erlotinib—ABCB1—hematopoietic system—malaria	0.000278	0.00243	CbGeAlD
Erlotinib—CYP1A1—liver—malaria	0.000278	0.00243	CbGeAlD
Erlotinib—Asthenia—Quinine—malaria	0.000277	0.00174	CcSEcCtD
Erlotinib—Asthenia—Quinidine—malaria	0.000277	0.00174	CcSEcCtD
Erlotinib—Abdominal pain—Quinidine barbiturate—malaria	0.000276	0.00173	CcSEcCtD
Erlotinib—Body temperature increased—Quinidine barbiturate—malaria	0.000276	0.00173	CcSEcCtD
Erlotinib—Abdominal pain—Pentoxifylline—malaria	0.000275	0.00172	CcSEcCtD
Erlotinib—Body temperature increased—Pentoxifylline—malaria	0.000275	0.00172	CcSEcCtD
Erlotinib—Pruritus—Quinine—malaria	0.000274	0.00171	CcSEcCtD
Erlotinib—Pruritus—Quinidine—malaria	0.000274	0.00171	CcSEcCtD
Erlotinib—CYP3A4—digestive system—malaria	0.000273	0.00239	CbGeAlD
Erlotinib—CYP3A5—liver—malaria	0.000271	0.00237	CbGeAlD
Erlotinib—Diarrhoea—Clindamycin—malaria	0.00027	0.00169	CcSEcCtD
Erlotinib—CYP2D6—digestive system—malaria	0.000269	0.00235	CbGeAlD
Erlotinib—Diarrhoea—Quinine—malaria	0.000265	0.00165	CcSEcCtD
Erlotinib—Diarrhoea—Quinidine—malaria	0.000265	0.00165	CcSEcCtD
Erlotinib—Dizziness—Clindamycin—malaria	0.000261	0.00163	CcSEcCtD
Erlotinib—CYP3A4—blood—malaria	0.000261	0.00228	CbGeAlD
Erlotinib—Vomiting—Dapsone—malaria	0.000259	0.00162	CcSEcCtD
Erlotinib—CYP2D6—blood—malaria	0.000256	0.00224	CbGeAlD
Erlotinib—Dizziness—Quinine—malaria	0.000256	0.0016	CcSEcCtD
Erlotinib—Dizziness—Quinidine—malaria	0.000256	0.0016	CcSEcCtD
Erlotinib—Headache—Dapsone—malaria	0.000255	0.0016	CcSEcCtD
Erlotinib—Vomiting—Clindamycin—malaria	0.000251	0.00157	CcSEcCtD
Erlotinib—Asthenia—Quinidine barbiturate—malaria	0.00025	0.00157	CcSEcCtD
Erlotinib—Asthenia—Pentoxifylline—malaria	0.00025	0.00156	CcSEcCtD
Erlotinib—Rash—Clindamycin—malaria	0.000249	0.00155	CcSEcCtD
Erlotinib—Dermatitis—Clindamycin—malaria	0.000248	0.00155	CcSEcCtD
Erlotinib—Headache—Clindamycin—malaria	0.000247	0.00154	CcSEcCtD
Erlotinib—Pruritus—Quinidine barbiturate—malaria	0.000247	0.00154	CcSEcCtD
Erlotinib—Pruritus—Pentoxifylline—malaria	0.000246	0.00154	CcSEcCtD
Erlotinib—Vomiting—Quinidine—malaria	0.000246	0.00154	CcSEcCtD
Erlotinib—Vomiting—Quinine—malaria	0.000246	0.00154	CcSEcCtD
Erlotinib—Rash—Quinidine—malaria	0.000244	0.00152	CcSEcCtD
Erlotinib—Rash—Quinine—malaria	0.000244	0.00152	CcSEcCtD
Erlotinib—Dermatitis—Quinine—malaria	0.000244	0.00152	CcSEcCtD
Erlotinib—Dermatitis—Quinidine—malaria	0.000244	0.00152	CcSEcCtD
Erlotinib—Headache—Quinine—malaria	0.000242	0.00152	CcSEcCtD
Erlotinib—Headache—Quinidine—malaria	0.000242	0.00152	CcSEcCtD
Erlotinib—Nausea—Dapsone—malaria	0.000242	0.00151	CcSEcCtD
Erlotinib—Diarrhoea—Quinidine barbiturate—malaria	0.000239	0.00149	CcSEcCtD
Erlotinib—CYP2C8—brain—malaria	0.000239	0.00209	CbGeAlD
Erlotinib—Diarrhoea—Pentoxifylline—malaria	0.000238	0.00149	CcSEcCtD
Erlotinib—Nausea—Clindamycin—malaria	0.000234	0.00146	CcSEcCtD
Erlotinib—ABCG2—brain—malaria	0.000232	0.00203	CbGeAlD
Erlotinib—Dizziness—Quinidine barbiturate—malaria	0.000231	0.00144	CcSEcCtD
Erlotinib—Dizziness—Pentoxifylline—malaria	0.00023	0.00144	CcSEcCtD
Erlotinib—Nausea—Quinidine—malaria	0.00023	0.00144	CcSEcCtD
Erlotinib—Nausea—Quinine—malaria	0.00023	0.00144	CcSEcCtD
Erlotinib—ABCB1—kidney—malaria	0.000228	0.00199	CbGeAlD
Erlotinib—Vomiting—Quinidine barbiturate—malaria	0.000222	0.00139	CcSEcCtD
Erlotinib—Vomiting—Pentoxifylline—malaria	0.000221	0.00139	CcSEcCtD
Erlotinib—CYP1A1—brain—malaria	0.00022	0.00192	CbGeAlD
Erlotinib—Rash—Quinidine barbiturate—malaria	0.00022	0.00138	CcSEcCtD
Erlotinib—Dermatitis—Quinidine barbiturate—malaria	0.00022	0.00137	CcSEcCtD
Erlotinib—Rash—Pentoxifylline—malaria	0.00022	0.00137	CcSEcCtD
Erlotinib—Dermatitis—Pentoxifylline—malaria	0.000219	0.00137	CcSEcCtD
Erlotinib—Headache—Quinidine barbiturate—malaria	0.000219	0.00137	CcSEcCtD
Erlotinib—Headache—Pentoxifylline—malaria	0.000218	0.00136	CcSEcCtD
Erlotinib—Nausea—Quinidine barbiturate—malaria	0.000207	0.0013	CcSEcCtD
Erlotinib—Nausea—Pentoxifylline—malaria	0.000207	0.00129	CcSEcCtD
Erlotinib—CYP3A4—liver—malaria	0.000204	0.00178	CbGeAlD
Erlotinib—CYP2D6—liver—malaria	0.0002	0.00175	CbGeAlD
Erlotinib—ABCB1—digestive system—malaria	0.000194	0.00169	CbGeAlD
Erlotinib—ABCB1—blood—malaria	0.000184	0.00161	CbGeAlD
Erlotinib—ABCB1—bone marrow—malaria	0.000178	0.00156	CbGeAlD
Erlotinib—CYP2D6—brain—malaria	0.000159	0.00139	CbGeAlD
Erlotinib—ABCB1—liver—malaria	0.000144	0.00126	CbGeAlD
Erlotinib—ABCB1—brain—malaria	0.000114	0.001	CbGeAlD
Erlotinib—MKNK1—Disease—NOS2—malaria	3.73e-05	0.000715	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—TNF—malaria	3.7e-05	0.000711	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—DECR1—malaria	3.7e-05	0.00071	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CD36—malaria	3.7e-05	0.00071	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—CD36—malaria	3.68e-05	0.000707	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—HBB—malaria	3.68e-05	0.000706	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—IL6—malaria	3.67e-05	0.000705	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—CD36—malaria	3.61e-05	0.000693	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—TNF—malaria	3.59e-05	0.000689	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	3.59e-05	0.000689	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PKLR—malaria	3.52e-05	0.000675	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TLR9—malaria	3.52e-05	0.000675	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	3.46e-05	0.000663	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	3.46e-05	0.000663	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—CD36—malaria	3.45e-05	0.000662	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—IL6—malaria	3.44e-05	0.000659	CbGpPWpGaD
Erlotinib—EGFR—Disease—G6PD—malaria	3.4e-05	0.000653	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—HBB—malaria	3.35e-05	0.000642	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CRP—malaria	3.34e-05	0.00064	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—DHODH—malaria	3.32e-05	0.000637	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—HLA-B—malaria	3.32e-05	0.000637	CbGpPWpGaD
Erlotinib—ABL1—Immune System—FCGR2A—malaria	3.29e-05	0.000631	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PKLR—malaria	3.28e-05	0.000629	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	3.27e-05	0.000627	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—IL6—malaria	3.26e-05	0.000625	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CD36—malaria	3.25e-05	0.000624	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—malaria	3.22e-05	0.000617	CbGpPWpGaD
Erlotinib—JAK3—Immune System—TLR4—malaria	3.2e-05	0.000614	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—KDR—malaria	3.18e-05	0.000611	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—CD36—malaria	3.15e-05	0.000604	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—DHODH—malaria	3.14e-05	0.000602	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—G6PD—malaria	3.14e-05	0.000602	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.08e-05	0.000592	CbGpPWpGaD
Erlotinib—JAK3—Immune System—ICAM1—malaria	3.07e-05	0.000589	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—TNF—malaria	3.04e-05	0.000584	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling by NGF—IL6—malaria	2.99e-05	0.000574	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—IL6—malaria	2.99e-05	0.000573	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PKLR—malaria	2.98e-05	0.000573	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—NOS2—malaria	2.97e-05	0.00057	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—TNF—malaria	2.94e-05	0.000565	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CRP—malaria	2.93e-05	0.000563	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—G6PD—malaria	2.92e-05	0.000561	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—IL6—malaria	2.9e-05	0.000556	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—CD36—malaria	2.88e-05	0.000554	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—DHODH—malaria	2.87e-05	0.000551	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD40LG—malaria	2.86e-05	0.000549	CbGpPWpGaD
Erlotinib—ALB—Metabolism—DHODH—malaria	2.86e-05	0.000548	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—HLA-B—malaria	2.84e-05	0.000544	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.83e-05	0.000543	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD8A—malaria	2.83e-05	0.000543	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.83e-05	0.000542	CbGpPWpGaD
Erlotinib—EGFR—Signaling by SCF-KIT—IL6—malaria	2.83e-05	0.000542	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—SLC4A1—malaria	2.82e-05	0.000541	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ACKR1—malaria	2.82e-05	0.000541	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—TLR4—malaria	2.81e-05	0.00054	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.81e-05	0.000539	CbGpPWpGaD
Erlotinib—EGFR—Immune System—FCGR2A—malaria	2.81e-05	0.000539	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—TNF—malaria	2.81e-05	0.000539	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CD36—malaria	2.78e-05	0.000533	CbGpPWpGaD
Erlotinib—MKNK1—Disease—CD4—malaria	2.76e-05	0.00053	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—malaria	2.75e-05	0.000527	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—KDR—malaria	2.74e-05	0.000526	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—HLA-B—malaria	2.72e-05	0.000522	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—KDR—malaria	2.72e-05	0.000522	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling of activated FGFR—IL6—malaria	2.7e-05	0.000519	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD36—malaria	2.67e-05	0.000512	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—SLC4A1—malaria	2.67e-05	0.000511	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB4—IL6—malaria	2.66e-05	0.000511	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—G6PD—malaria	2.66e-05	0.00051	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—DECR1—malaria	2.65e-05	0.000509	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.6e-05	0.000498	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.58e-05	0.000495	CbGpPWpGaD
Erlotinib—EGFR—Downstream signal transduction—IL6—malaria	2.54e-05	0.000488	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR—IL6—malaria	2.53e-05	0.000485	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB2—IL6—malaria	2.52e-05	0.000483	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CRP—malaria	2.51e-05	0.000481	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—DECR1—malaria	2.51e-05	0.000481	CbGpPWpGaD
Erlotinib—EGFR—DAP12 signaling—IL6—malaria	2.5e-05	0.000481	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—DHODH—malaria	2.5e-05	0.00048	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—IL2—malaria	2.5e-05	0.00048	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—SLC4A1—malaria	2.44e-05	0.000469	CbGpPWpGaD
Erlotinib—ALB—Metabolism—SLC4A1—malaria	2.43e-05	0.000466	CbGpPWpGaD
Erlotinib—EGFR—Disease—DHFR—malaria	2.41e-05	0.000462	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—TLR4—malaria	2.4e-05	0.000461	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—HBB—malaria	2.4e-05	0.00046	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—HPGDS—malaria	2.39e-05	0.000459	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—IL6—malaria	2.37e-05	0.000456	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—DHODH—malaria	2.36e-05	0.000453	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR in disease—IL6—malaria	2.36e-05	0.000452	CbGpPWpGaD
Erlotinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—malaria	2.36e-05	0.000452	CbGpPWpGaD
Erlotinib—EGFR—DAP12 interactions—IL6—malaria	2.36e-05	0.000452	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR—IL6—malaria	2.34e-05	0.000448	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IFNG—malaria	2.33e-05	0.000448	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR in Cancer—IL6—malaria	2.31e-05	0.000444	CbGpPWpGaD
Erlotinib—EGFR—Signaling by PDGF—IL6—malaria	2.3e-05	0.000442	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—DECR1—malaria	2.3e-05	0.000441	CbGpPWpGaD
Erlotinib—ALB—Metabolism—DECR1—malaria	2.28e-05	0.000438	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TLR9—malaria	2.27e-05	0.000436	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—IL2—malaria	2.27e-05	0.000436	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—HBB—malaria	2.27e-05	0.000435	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CD4—malaria	2.25e-05	0.000433	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—HPGDS—malaria	2.23e-05	0.000428	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—DHFR—malaria	2.22e-05	0.000426	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—ICAM1—malaria	2.21e-05	0.000424	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—SCARB1—malaria	2.2e-05	0.000421	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PKLR—malaria	2.14e-05	0.00041	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—SLC4A1—malaria	2.13e-05	0.000409	CbGpPWpGaD
Erlotinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—malaria	2.09e-05	0.0004	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL1B—malaria	2.08e-05	0.000399	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—HBB—malaria	2.08e-05	0.000399	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL2—malaria	2.07e-05	0.000398	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—DHFR—malaria	2.07e-05	0.000397	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—KDR—malaria	2.07e-05	0.000397	CbGpPWpGaD
Erlotinib—ALB—Metabolism—HBB—malaria	2.07e-05	0.000396	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—SCARB1—malaria	2.05e-05	0.000393	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL18—malaria	2.04e-05	0.000391	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD40LG—malaria	2.03e-05	0.00039	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—HPGDS—malaria	2.03e-05	0.000389	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—IL2—malaria	2.02e-05	0.000389	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PKLR—malaria	2.02e-05	0.000388	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	2.02e-05	0.000387	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD8A—malaria	2.01e-05	0.000385	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—SLC4A1—malaria	2.01e-05	0.000385	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—DECR1—malaria	2e-05	0.000384	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—DHODH—malaria	2e-05	0.000384	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CD4—malaria	1.98e-05	0.00038	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.97e-05	0.000377	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—IL2—malaria	1.93e-05	0.000371	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HLA-B—malaria	1.93e-05	0.000371	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—G6PD—malaria	1.91e-05	0.000366	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD36—malaria	1.89e-05	0.000364	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—DECR1—malaria	1.89e-05	0.000362	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—DHFR—malaria	1.88e-05	0.000361	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—SCARB1—malaria	1.86e-05	0.000357	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PKLR—malaria	1.85e-05	0.000355	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PKLR—malaria	1.84e-05	0.000353	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—HBB—malaria	1.81e-05	0.000347	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.81e-05	0.000346	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—G6PD—malaria	1.8e-05	0.000345	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—CD36—malaria	1.78e-05	0.000341	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL2—malaria	1.78e-05	0.000341	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—CD36—malaria	1.78e-05	0.000341	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL18—malaria	1.74e-05	0.000334	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD40LG—malaria	1.74e-05	0.000333	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD8A—malaria	1.72e-05	0.000329	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CRP—malaria	1.71e-05	0.000328	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—HBB—malaria	1.71e-05	0.000327	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—IL6—malaria	1.7e-05	0.000326	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SLC4A1—malaria	1.7e-05	0.000326	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CD4—malaria	1.69e-05	0.000325	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—KDR—malaria	1.69e-05	0.000324	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-B—malaria	1.65e-05	0.000317	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—G6PD—malaria	1.65e-05	0.000317	CbGpPWpGaD
Erlotinib—ALB—Metabolism—G6PD—malaria	1.64e-05	0.000315	CbGpPWpGaD
Erlotinib—ABL1—Immune System—TLR4—malaria	1.64e-05	0.000314	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	1.63e-05	0.000313	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD4—malaria	1.63e-05	0.000312	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	1.62e-05	0.000311	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD36—malaria	1.62e-05	0.000311	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PKLR—malaria	1.61e-05	0.00031	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—IL6—malaria	1.61e-05	0.000308	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—DECR1—malaria	1.6e-05	0.000307	CbGpPWpGaD
Erlotinib—ABL1—Immune System—ICAM1—malaria	1.57e-05	0.000301	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—DHODH—malaria	1.54e-05	0.000296	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PKLR—malaria	1.52e-05	0.000292	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TNF—malaria	1.5e-05	0.000288	CbGpPWpGaD
Erlotinib—MKNK1—Disease—IL6—malaria	1.49e-05	0.000286	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—NOS2—malaria	1.46e-05	0.000281	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CRP—malaria	1.46e-05	0.00028	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—HPGDS—malaria	1.45e-05	0.000279	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—IL6—malaria	1.45e-05	0.000279	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—HBB—malaria	1.45e-05	0.000277	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—G6PD—malaria	1.44e-05	0.000276	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TLR4—malaria	1.4e-05	0.000269	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.39e-05	0.000266	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CD36—malaria	1.38e-05	0.000264	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—HPGDS—malaria	1.37e-05	0.000263	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—G6PD—malaria	1.36e-05	0.00026	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—DHFR—malaria	1.35e-05	0.000259	CbGpPWpGaD
Erlotinib—EGFR—Immune System—ICAM1—malaria	1.34e-05	0.000257	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL2—malaria	1.34e-05	0.000257	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—SCARB1—malaria	1.33e-05	0.000256	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—IL6—malaria	1.33e-05	0.000256	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SLC4A1—malaria	1.31e-05	0.000252	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PKLR—malaria	1.29e-05	0.000247	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CD36—malaria	1.28e-05	0.000247	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TNF—malaria	1.28e-05	0.000246	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—DHFR—malaria	1.27e-05	0.000244	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—SCARB1—malaria	1.26e-05	0.000242	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—HPGDS—malaria	1.26e-05	0.000242	CbGpPWpGaD
Erlotinib—ALB—Metabolism—HPGDS—malaria	1.25e-05	0.00024	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—DECR1—malaria	1.23e-05	0.000237	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS2—malaria	1.23e-05	0.000236	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL6—malaria	1.22e-05	0.000234	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—IL6—malaria	1.21e-05	0.000233	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IFNG—malaria	1.19e-05	0.000229	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CD36—malaria	1.17e-05	0.000224	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—DHFR—malaria	1.17e-05	0.000224	CbGpPWpGaD
Erlotinib—ALB—Metabolism—DHFR—malaria	1.16e-05	0.000223	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—SCARB1—malaria	1.16e-05	0.000222	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD4—malaria	1.15e-05	0.000221	CbGpPWpGaD
Erlotinib—ALB—Metabolism—SCARB1—malaria	1.15e-05	0.000221	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—G6PD—malaria	1.15e-05	0.00022	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	1.13e-05	0.000217	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HBB—malaria	1.12e-05	0.000214	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—HPGDS—malaria	1.1e-05	0.00021	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL2—malaria	1.09e-05	0.00021	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—IL6—malaria	1.07e-05	0.000206	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1B—malaria	1.07e-05	0.000204	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL2—malaria	1.06e-05	0.000204	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL6—malaria	1.05e-05	0.000201	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—IL6—malaria	1.04e-05	0.000199	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—HPGDS—malaria	1.03e-05	0.000198	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IFNG—malaria	1.02e-05	0.000196	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—DHFR—malaria	1.02e-05	0.000195	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—SCARB1—malaria	1.01e-05	0.000193	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—IL2—malaria	9.97e-06	0.000191	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PKLR—malaria	9.94e-06	0.000191	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL2—malaria	9.93e-06	0.000191	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD4—malaria	9.86e-06	0.000189	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—DHFR—malaria	9.59e-06	0.000184	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—SCARB1—malaria	9.49e-06	0.000182	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—IL6—malaria	9.16e-06	0.000176	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1B—malaria	9.11e-06	0.000175	CbGpPWpGaD
Erlotinib—EGFR—Disease—CD4—malaria	9.1e-06	0.000175	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL2—malaria	9.07e-06	0.000174	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—KDR—malaria	9.05e-06	0.000174	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—G6PD—malaria	8.86e-06	0.00017	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—HPGDS—malaria	8.76e-06	0.000168	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CD36—malaria	8.37e-06	0.000161	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—DHFR—malaria	8.12e-06	0.000156	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SCARB1—malaria	8.04e-06	0.000154	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CD36—malaria	7.91e-06	0.000152	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL6—malaria	7.88e-06	0.000151	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CD36—malaria	7.25e-06	0.000139	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CD36—malaria	7.21e-06	0.000138	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HPGDS—malaria	6.76e-06	0.00013	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6—malaria	6.42e-06	0.000123	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CD36—malaria	6.32e-06	0.000121	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—DHFR—malaria	6.27e-06	0.00012	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6—malaria	6.24e-06	0.00012	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SCARB1—malaria	6.2e-06	0.000119	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CD36—malaria	5.96e-06	0.000114	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL2—malaria	5.87e-06	0.000113	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6—malaria	5.84e-06	0.000112	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6—malaria	5.33e-06	0.000102	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CD36—malaria	5.04e-06	9.68e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6—malaria	4.92e-06	9.45e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CD36—malaria	3.89e-06	7.47e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6—malaria	3.45e-06	6.62e-05	CbGpPWpGaD
